AiCuris Received 15 Million Euros Milestone Payment from Licensing Partner MSD Following EMA Approval of PREVYMIS(R) for Prevention of CMV Infection in High-Risk Adult Kidney Transplant Recipients lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
PREVYMIS® now approved in the U.S. and Europe for prophylaxis of Cytomegalovirus (CMV) disease in adult kidney transplant recipients at high risk (Donor CMV seropositive/Recipient CMV seronegative [D+/R‑])EMA approval triggers a €15 Million Milestone payment to AiCuris and AiCuris is eligible for further milestone p.
Muskogee man has hearing date set muskogeephoenix.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from muskogeephoenix.com Daily Mail and Mail on Sunday newspapers.